REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing

Mycelx TechnologiesAnnouncement

21/05/2025 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250521:nRSU6532Ja&default-theme=true

RNS Number : 6532J  MyCelx Technologies Corporation  21 May 2025

21 May 2025

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Director Dealing

 

The Company announces that it was notified by Connie Mixon, Chief Executive
Officer and Director of the Company, that on 21 May 2025, she purchased 73,500
common shares in the Company of US$0.025 each ("Common Shares"), at a price of
£0.26415 per Common Share. Following this transaction, Mrs. Mixon holds
2,776,068 Common Shares representing 11.39 per cent of the total issued
capital of the Company. In addition, the spouse of Mrs. Mixon also holds
229,008 shares in the Company.

 

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                                      Tel: +1 888 306 6843

 Kim Slayton, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

 Giles Balleny (Corporate Finance)                                      Tel: +44 20 7523 8000

 Jamie Anderson (Corporate Broking)

 Jasper Berry / Michael Johnson (Sales)

 Celicourt Communications (Financial PR)

 Mark Antelme                                                           Tel: +44 20 2770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

Notification of transactions of persons discharging managerial responsibility
or connected persons

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Connie Mixon

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer and Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         MYCELX Technologies Corporation

 b)   LEI                                                          213800UJZINIK2VD1G48

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument

                                                                   Common shares of US$0.025

                                                                   ISIN: US62847T2024

 b)   Nature of the transaction                                    Purchase of Common Shares in GBP

 c)   Price(s) and volume(s)

Price(s)    Volume(s)

                                                                   £0.26415    73,500

 

 d)   Aggregated information

      - Aggregated volume                                          n/a

      - Price                                                      n/a

 e)   Date of the transaction                                      21/05/2025

 f)   Place of the transaction                                     London Stock Exchange (AIM)

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

21/05/2025

f)

 

Place of the transaction

 

 

London Stock Exchange (AIM)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFSEVILFIE